| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |